Skip to main content

Day: May 25, 2020

Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19

VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has submitted an Investigational New Drug (IND) application with the U.S. FDA for its planned multinational Phase 2b/3 study of its re-purposed drug NP-120 (Ifenprodil) as a potential therapeutic treatment for patients with COVID-19. Ifenprodil is an NMDA receptor antagonist.The clinical study for Ifenprodil, 20 mg tablets, is entitled, “A Randomized Open Label Phase 2b/3 Study of the Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients.” As part of the multinational Phase 2b/3 COVID-19 clinical study, Algernon has...

Continue reading

REPEAT – Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors

VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to augment its board of directors through the appointment of accomplished business executives and thought leaders with successful track records of advancing research and awareness within the arena of depression, post-traumatic stress disorder (“PTSD”), and substance abuse disorders (“DPS”). To this accord, Champignon is pleased to appoint Dr. Bill Wilkerson, LL.D. (Hon) to its board of directors.An executive equipped with extensive service in business, government, broadcasting, the arts, and corporate crisis management, Dr. Wilkerson is an 8-time award-winning pioneer in workplace...

Continue reading

Rogers Brings Its Store-to-the-Door to Ottawa With Pro On-the-Go Expansion

Rogers Pro On-the-Go™ expands to nation’s capital, with contactless phone delivery and set-up support, in as little as hours of orderAs province begins to reopen amid COVID-19, adapted Pro On-the-Go™ service is latest Rogers initiative to provide safe contactless customer support and delivery optionsOTTAWA, May 25, 2020 (GLOBE NEWSWIRE) —  Rogers announced that its personalized mobile retail experience, Rogers Pro On-the-Go™, is now available in the nation’s capital. As restrictions in the province start to ease, and businesses pivot to meet the needs of Canadians in the new normal,  Rogers has accelerated the expansion of Pro On-the-Go™ to give customers in Ottawa another way to get a new phone in as little as hours and expert support to set it up, at no extra cost.The service, available only at Rogers, has begun rolling out to...

Continue reading

Rogers propose son service à la porte dans la région d’Ottawa grâce à l’expansion de son service Pro chez vous

Le service Pro chez vousMC de Rogers s’étend jusqu’à Ottawa et comprend la livraison du téléphone et le soutien à la configuration sans contact, le tout quelques heures seulement après la réception de la commande.Dans le cadre d’un début de relance économique en Ontario, l’expansion du service Pro chez vousMC adapté constitue la plus récente initiative de Rogers visant à offrir un service de soutien à la clientèle et des options de livraison sécuritaires et sans contact.OTTAWA, 25 mai 2020 (GLOBE NEWSWIRE) —  Rogers a annoncé que son expérience de vente au détail mobile personnalisée, le service Pro chez vousMC de Rogers, est maintenant offerte dans la capitale nationale. Tandis que les restrictions commencent à s’assouplir dans la province et que les entreprises s’ajustent pour répondre aux besoins des Canadiens dans le cadre d’une...

Continue reading

TC Energy completes partial monetization and project financing transactions for Coastal GasLink

CALGARY, Alberta, May 25, 2020 (GLOBE NEWSWIRE) — News Release — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) announced today that it has completed the sale of a 65 per cent equity interest in the Coastal GasLink Pipeline Project (Coastal GasLink or the Project). In addition, the Coastal GasLink Pipeline Limited Partnership has executed a credit agreement with a syndicate of banks extending non-recourse project-level financing to fund the majority of the construction costs for the Project which, with the closing of the equity sale, are available to be drawn.  Together, these transactions have resulted in the Company realizing immediate proceeds of approximately $2.1 billion.About TC Energy We are a vital part of everyday life – delivering the energy millions of people rely on to power their lives in a...

Continue reading

Bang & Olufsen A/S – financial calendar

Please be informed of the following dates for Bang & Olufsen’s planned announcements to NASDAQ Copenhagen A/S, including dates for Annual General Meetings in 2020 and 2021. Interim reports and annual reports are expected to be published in the morning on the listed dates.2020Wednesday 3 June         Extraordinary General MeetingTuesday 7 July                Annual report 2019/20Thursday 20 August        Annual General Meeting                                        (Deadline for subjects and proposals to the agenda is 9 July)Thursday 1 October        Interim report (1st quarter 2020/21)2021Tuesday 12 January       Interim report (2nd quarter 2020/21)Thursday 8 April              Interim report (3rd quarter 2020/21)Wednesday 7 July          Annual report 2020/21Thursday 19 August        Annual General Meeting                                       ...

Continue reading

Bang & Olufsen A/S – finanskalender

Herved følger offentliggørelsesdatoer for Bang & Olufsens planlagte selskabsmeddelelser til NASDAQ Copenhagen A/S, herunder også datoer for generalforsamlinger i 2020 og 2021. Delårsrapporter og årsrapport vil blive offentliggjort de anførte datoer om morgenen.2020Onsdag 3. juni                 Ekstraordinær generalforsamlingTirsdag 7. juli                   Årsrapport 2019/20Torsdag 20. august         Generalforsamling                                        (Seneste frist for emner til dagsordenen er 9. juli)Torsdag 1. oktober          Delårsrapport (1. kvartal 2020/21)2021Tirsdag 12. januar           Delårsrapport (2. kvartal 2020/21)Torsday 8. april               Delårsrapport (3. kvartal 2020/21)Onsdag 7. juli                  Årsrapport 2020/21Torsdag 19. august         Generalforsamling                                       ...

Continue reading

Dentsply Sirona to Present at the Stifel 2020 Virtual Jaws and Paws Conference on May 27th

CHARLOTTE, N.C., May 25, 2020 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the Stifel 2020 Jaws and Paws Conference on May 27th.Don Casey, Chief Executive Officer, will represent the company and is scheduled to participate in a fireside chat at 4:45PM Eastern Time.  Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting www.dentsplysirona.com.  A replay of the presentation will also be available on the Dentsply Sirona website at www.dentsplysirona.com.About Dentsply SironaDentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 132-year history of innovation and service to the dental industry and patients worldwide. ...

Continue reading

Kalytera Issues CEO Letter to Shareholders

SAN FRANCISCO, May 25, 2020 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) today issued the following letter to shareholders from the Company’s President and CEO, Robert Farrell.Dear Kalytera Shareholders,I would like to underscore the importance of the transaction that we announced last week, and provide an update on our programs in prevention and treatment of graft versus host disease and in treatment of pain.On Tuesday last week, we announced that Kalytera has signed a Letter of Intent to acquire Salzman Group, Inc. (“Salzman Group”).  On close of this transaction, Kalytera will have a new pharmaceutical development program, developing R-107 for three indications, including treatment of COVID-19 associated lung disease, chlorine inhalation...

Continue reading

MediPharm Labs and Ace Valley Deliver Innovative Vapes – Now Available in Several Markets Across Canada

TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its highly anticipated and innovative suite of “Ace Valley Vapes” are officially available in several markets across Canada.   The Company shipped three new vape products under this white label brand-line to multiple provinces last week.The launch of the Ace Valley Vapes is the culmination of the Company’s previously announced white label agreement through its subsidiary, MediPharm Labs Inc., with AV Cannabis Inc. (d/b/a Ace Valley). Through this collaboration, Ace Valley leveraged its leading brand traction and product strategy expertise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.